DIAMOND (Completed)
A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Medications for the Treatment of HF.
- Medicine
- Patiromer
- Population
- Heart failure
- Phase
- IIIb
- Starting year
- 2019
- More information
- Clinicaltrials.gov